Quantum's Public-Market Wave Sets New Anchors for Pre-IPO Secondaries

The quantum computing sector crossed a threshold in the last five weeks that will reshape how allocators price pre-IPO paper for the balance of the decade. Between June 5 and July 2, four events converged: Quantinuum priced its long-anticipated IPO, IQM Quantum Computers closed a business combination with dMY Squared to become the first pure-play European quantum computing company on public markets, Germany's Quantum Systems more than doubled its private valuation to $8 billion, and IonQ activated Forte Enterprise AQ36 as the highest-fidelity commercially available quantum system in Europe. Taken together, these events establish the first genuine public-market comparable set for the category and give secondary buyers something they have not had in three years of quantum enthusiasm: benchmarks.

The Quantinuum listing matters most for pricing discovery. As Yahoo Finance reported, Wall Street rallied around the shares in the days following the debut, giving analysts a live tape against which to mark private-market quantum positions. Before this listing, secondary buyers pricing shares in PsiQuantum, Quantum Systems, or IonQ competitors were triangulating from D-Wave and Rigetti — thinly traded microcaps with capital structures that bear little resemblance to venture-scale quantum businesses. Now there is a large-cap, institutionally held quantum stock whose float is being priced daily by fundamental funds. Every private-market bid on a quantum name will reference it.

The European vector is the more interesting story for allocators. IQM completed its SPAC merger with dMY Squared on July 2 alongside a fresh commitment from Finnish pension fund Ilmarinen to the PIPE, per Data Center Dynamics. The transaction created the first European quantum computing pure-play on public markets and did so with a pension-fund anchor — signaling that regulated Nordic capital is willing to underwrite the category at scale. In parallel, Bloomberg reported that Germany's Quantum Systems raised at $8 billion — a valuation that would have looked aggressive against 2024 comparables but now sits inside the range implied by IQM's post-merger enterprise value and Quantinuum's post-IPO trading multiple.

What the Public Comparables Actually Say

Three signals matter for anyone marking private quantum positions:

• Revenue multiples are compressing toward hardware norms. Quantinuum trades on forward hardware and service revenue, not the pure-optionality multiples applied to Rigetti and D-Wave during the 2024 retail bid. That reference point drags secondary marks toward disciplined DCF territory for the first time.
• Geographic premium is real. European quantum names are pricing at a discount to US comparables on revenue-adjusted metrics despite comparable technical roadmaps. IQM's post-SPAC EV against Quantinuum's cap creates a testable geographic arbitrage that private-market allocators can act on before it closes.
• Milestone-driven repricing has arrived. IonQ's Forte Enterprise activation in Europe at AQ36 — described by the company's Ritzau announcement as the highest-fidelity commercially available system in the region — is exactly the kind of specification-tied catalyst that fundamental analysts can model. Expect private-market secondary bids to now price these milestones the way biotech secondaries price Phase 2 readouts.

Secondary Market Reads

The clearest live read for private-market pricing sits on the Nasdaq Private Market tape. PsiQuantum, the highest-profile pure-play private quantum name, most recently cleared at $33.34 per share in the NPM auction on June 17 per Nasdaq Private Market's company page. That print landed before the Quantinuum listing set a public comparable and before Quantum Systems repriced upward. The next NPM window for PsiQuantum will be the first true test of whether public-market discovery flows through to private secondaries — historically the transmission takes three to six weeks, and this cycle should compress given how visible the public prints have been.

Two behaviors to watch on Hiive, Forge, and EquityZen over the next month:

1. Spread compression on European quantum names. Bid-ask spreads on IQM peers and adjacent European quantum secondaries should narrow now that IQM has a public reference. Wide spreads have historically reflected pricing uncertainty; a live tape kills that excuse.
2. Widening dispersion between hardware and software quantum names. Quantinuum's public trading provides a hardware benchmark. Private quantum software plays — error correction, control systems, algorithm libraries — do not have an equivalent. Expect the software cohort to be repriced downward as buyers demand hardware-referenced comps that don't exist for the category.

The Policy Tailwind Is Already Priced

The $2 billion CHIPS Act quantum allocation disbursed in late May remains the largest single US policy commitment to the sector and was widely referenced in Quantinuum's IPO marketing. That capital has now been counted in every public prospectus and PIPE deck. Allocators pricing new private rounds should assume the policy premium is baked in — future secondary buyers will not pay again for the same subsidy story. The differentiated bid over the next six months will go to names with commercial revenue in a customer's production stack, not to names with a research-lab customer list.

Research Positioning

AdValorem publishes weekly research on the pre-IPO quantum cohort as part of our frontier-technology coverage. Our Quantum Pre-IPO vertical tracks NPM auction prints, Hiive tape movements, and the SPAC-and-direct-listing pipeline against public comparables — the exact triangulation that will determine private-market marks through the back half of the year. As the public tape gives analysts real comps for the first time, disciplined secondary allocation is about to become substantially more analyzable, and substantially less forgiving of narrative-only positions.